Mulay SR, Kulkarni OP, Rupanagudi KV et al (2013) Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1 secretion
From 2008-2010, Sanofi-Aventis Acomplia (selective CB1 antagonist) and Abbott Laboratories Meridia (NE/5-HT reuptake inhibitor)--both also designed to suppress appetite--were pulled from the market over similar cardiac safety concerns
Track how your injection works throughout the week
pylori shed by infected people
When to Seek Medical Advice : Patients should contact their healthcare provider if they experience unexplained bone pain, height loss, or fractures with minimal trauma, as these may indicate significant bone loss requiring evaluation and intervention
They provide a foundation for both healthcare professionals and patients to further explore and understand the complexities of this medication and its implications for health and well-being